Schonfeld Strategic Advisors’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.9K Buy
+1,661
New +$37.1K ﹤0.01% 2446
2025
Q3
– Sell
-11,217
Closed -$1.1M – 2339
2025
Q2
$1.1M Buy
11,217
+8,696
+345% +$759K 0.01% 1264
2025
Q1
$222K Buy
2,521
+587
+30% +$54.3K ﹤0.01% 1905
2024
Q4
$140K Sell
1,934
-1,024
-35% -$70.2K ﹤0.01% 1813
2024
Q3
$233K Sell
2,958
-11,495
-80% -$885K ﹤0.01% 1757
2024
Q2
$1.04M Buy
14,453
+12,196
+540% +$730K 0.01% 1191
2024
Q1
$213K Sell
2,257
-2,364
-51% -$208K ﹤0.01% 1758
2023
Q4
$337K Buy
4,621
+122
+3% +$7.21K ﹤0.01% 1397
2023
Q3
$300K Sell
4,499
-319
-7% -$29.4K ﹤0.01% 1326
2023
Q2
$462K Sell
4,818
-80
-2% -$7.97K ﹤0.01% 1250
2023
Q1
$494K Sell
4,898
-6,396
-57% -$979K ﹤0.01% 1174
2022
Q4
$1.96M Buy
11,294
+9,677
+598% +$6.37M 0.02% 828
2022
Q3
$1.55M Buy
1,617
+1,145
+243% +$1.14M 0.01% 1002
2022
Q2
$315K Sell
472
-723
-61% -$448K ﹤0.01% 1637
2022
Q1
$830K Sell
1,195
-336
-22% -$259K 0.01% 1085
2021
Q4
$1.39M Buy
1,531
+277
+22% +$263K 0.01% 805
2021
Q3
$1.26M Buy
+1,254
New +$923K 0.01% 872
2021
Q2
– Sell
-624
Closed -$461K – 2076
2021
Q1
$461K Buy
624
+76
+14% +$61.3K 0.01% 1177
2020
Q4
$423K Buy
+548
New +$432K 0.01% 1095

Other funds holding GOSS

Schonfeld Strategic Advisors's GOSS Position: Q2 2026 in Review

Schonfeld Strategic Advisors opened a new position in Gossamer Bio (GOSS) in Q2 2026: 1,661 shares worth $21.9K. The stake represents ﹤0.01% of the portfolio and ranks #2446 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in GOSS as recently as Q2 2025.

Schonfeld Strategic Advisors first reported a position in GOSS in Q4 2020 and has held it in 19 quarters since. The position peaked at $1.96M in Q4 2022. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Schonfeld Strategic Advisors held 1,661 shares of Gossamer Bio worth $21.9K as of Q2 2026.
  • Gossamer Bio was a new Schonfeld Strategic Advisors position in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #2446 holding.
  • Schonfeld Strategic Advisors first reported a position in Gossamer Bio in Q4 2020 and has held it in 19 quarters since.
  • Schonfeld Strategic Advisors's Gossamer Bio position peaked at $1.96M in Q4 2022.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.